Lorenzo Bosisio

Mr. Bosisio, CEO of EffRx Pharmaceuticals since 2016, has solid experience across different therapeutic areas in bringing medicines from the development stage to the market. He served as Chief Commercial Officer for Tissot Medical Research and as EMEA Marketing Director for Alexion. During his 9 years tenure with Amgen, he built from scratch the international commercial infrastructure for the flagship drug denosumab, launched Prolia®, optimized Aranesp® and launched Mimpara®. At PwC Switzerland he led Marketing and Business Development for its major practice. Earlier in his career, he set up the commercial organization and led Marketing & Sales for a start-up.

Mr. Bosisio holds a BSc in Economics & Business Administration and has earned an MBA from HEC School of Management, Paris.